1997
DOI: 10.1016/s0014-2999(97)83026-9
|View full text |Cite
|
Sign up to set email alerts
|

Nω-Nitro-l-arginine methyl ester protects retinal neurons against N-methyl-d-aspartate-induced neurotoxicity in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
39
0

Year Published

1999
1999
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(40 citation statements)
references
References 19 publications
1
39
0
Order By: Relevance
“…23 These results establish a causal role of peroxynitrite in mediating retinal neurotoxicity and lend further support to previous reports showing protective effects of blocking peroxynitrite indirectly using the NOS inhibitor L-NAME, iNOS inhibitor aminoguanidine, or the superoxides and hydroxyl radicals scavenger TEMPOL in NMDA or ischemia/reperfusion model. 1,2,24,25 The neuroprotective effects of FeTPPs were screened after 1 day of NMDA injection, a time point at which, RGC death will peak then plateau afterward. 1,26 Indeed, peroxynitrite decomposition catalysts, such as FeTPPs and FP15 have been proven effective in reducing peroxynitrite-mediated insults in models of ischemic retinopathy, diabetic retinopathy, and neuropathy.…”
Section: Figure 5 Fetpps Blocked Activation Of P38 Mapk Apoptosis Pamentioning
confidence: 99%
“…23 These results establish a causal role of peroxynitrite in mediating retinal neurotoxicity and lend further support to previous reports showing protective effects of blocking peroxynitrite indirectly using the NOS inhibitor L-NAME, iNOS inhibitor aminoguanidine, or the superoxides and hydroxyl radicals scavenger TEMPOL in NMDA or ischemia/reperfusion model. 1,2,24,25 The neuroprotective effects of FeTPPs were screened after 1 day of NMDA injection, a time point at which, RGC death will peak then plateau afterward. 1,26 Indeed, peroxynitrite decomposition catalysts, such as FeTPPs and FP15 have been proven effective in reducing peroxynitrite-mediated insults in models of ischemic retinopathy, diabetic retinopathy, and neuropathy.…”
Section: Figure 5 Fetpps Blocked Activation Of P38 Mapk Apoptosis Pamentioning
confidence: 99%
“…Intravitreal injections were carried out as previously described (31). Fasudil was dissolved in intraocular irrigating solution (OpeguardMA, Senju Pharmaceutical, Osaka, Japan).…”
Section: Methodsmentioning
confidence: 99%
“…The excitotoxic RGC injury model was prepared in a manner similar to that previously described [22,23]. After anaesthetising the rats with isoflurane (2.5 L/min isoflurane in 2.5 L/min oxygen), instilling topical 0.4% benoxinate drops in both eyes and applying a sterile loop around the globes, a single dose of 5 μl of 4 mM NMDA (20 nmol, source- Sigma Aldrich, USA) was injected slowly over 30 seconds into the vitreous space of the left eye using a microsyringe fitted with a 30-gauge needle.…”
Section: Methodsmentioning
confidence: 99%